Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFrom 1 September 2025, the cost of Mounjaro in the UK rose substantially. Eli Lilly increased the list price of the highest-dose pen from around £122 to around £330, and private providers adjusted their prices accordingly — typically ranging from roughly £149 to £375 per month depending on the dose. That is the honest answer. The rest of this page explains how that price increase came about, what a legitimate private price actually covers, and what to weigh up before deciding where to get treatment. Mounjaro is a prescription-only medicine; a clinical assessment by a qualified prescriber is required before any treatment can be dispensed, and the right provider matters as much as the number on the price tag.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The September price shift was driven by Eli Lilly, Mounjaro's manufacturer, not by pharmacies or clinics. Before 1 September 2025, the pen carrying the highest maintenance doses was listed at around £122. After that date, the same pen was listed at around £330. Pharmacies that source through the licensed UK supply chain (as any legitimate provider must) had no option but to reflect that increase.
What that means in practice is that anyone comparing Mounjaro prices from a quote they received before September is comparing the wrong numbers. If a provider is still quoting a price far below the current market range, that is worth scrutinising carefully. Genuinely low prices for a prescription-only medicine are rarely what they appear. The MHRA has issued repeated warnings about counterfeit weight-loss pens sold online, some of which have reached patients through channels that looked, at a glance, like legitimate pharmacies.
For a fuller picture of exactly how much Mounjaro will cost from September, including which doses were affected and by how much, our breakdown of the September price rise covers the detail by strength.
A headline monthly price for Mounjaro sometimes covers the pen and nothing else. Clinical consultation fees, prescription fees, delivery charges, and any form of ongoing prescriber support can all be billed separately. Add those together and the true monthly cost often climbs well above what was advertised.
This is worth thinking through carefully if you are moving between providers or starting treatment for the first time. A lower advertised price might mean a per-pen charge plus £30 for a prescription plus a delivery fee each month. It might also mean no structured aftercare if you experience side effects, or no clinical review before your dose is increased.
Dose increases are not automatic. A responsible prescriber will ask for evidence that your current dose is working and that you are tolerating it before moving up the schedule. That process takes time and clinical judgement, and it should not be skipped. If you want to understand how much Mounjaro is going up to in September across the different dose strengths, that detail is worth reviewing before you budget for a full course of treatment. You can read more about how the dosing schedule works and what a full treatment journey looks like on our Mounjaro overview page.
Our weight loss treatment page sets out the broader context of what a medically supervised programme involves, beyond the prescription itself.
We are not the cheapest option you will find. That is a deliberate choice. Our single transparent price covers the clinical consultation, the prescription issued by our GPhC-registered Independent Prescriber, the treatment itself sourced through the licensed UK supply chain, and free next-working-day delivery via DPD. There are no separate fees at any of those stages, no subscription and no automatic repeat charges. Every repeat order is reviewed by a prescriber before it goes out.
When the pen arrives, it comes in plain unbranded packaging, tracked to your door. The KwikPen inside is a pre-filled device containing four weekly doses; it needs to be stored in the fridge when you get it home, and the Patient Information Leaflet inside the box covers the detail on that.
Our current treatment pricing is listed on our free consultation and treatment page, where you can also begin your assessment. We do not print per-pen prices in our editorial content because they can move, but our page covering the Mounjaro price from 1st September sets out exactly what changed and when; the treatment page always reflects what is current. You can verify that our pharmacy is GPhC-registered at registration number 9012878 on the GPhC register.
For a close look at how providers are currently pricing across different doses, the Mounjaro price guide offers a practical comparison of the market context.
The most important thing about any Mounjaro provider is not what they charge, it is whether they are dispensing a genuine medicine, following a proper clinical process, and keeping you safe throughout treatment. For a prescription-only medicine, sourcing from an unverified seller is a serious risk. The MHRA has documented cases of counterfeit pens that contained insulin instead of tirzepatide, and has raided illicit manufacturing sites producing fake tirzepatide pens in the UK. Sellers who offer these medicines without a full prescribing assessment, or at prices far outside the current market range, are a red flag, and our coverage of the Mounjaro price increase news explains why some unexpectedly low prices circulating online are worth treating with caution.
The right questions are: is this pharmacy verifiable on the GPhC register? Is a real prescriber reviewing my case? Is the medicine coming from the licensed supply chain? If you can answer yes to all three, you are on solid ground, and then price is a fair thing to compare.
Our clinical team oversees every prescription issued through nume. If you have questions about whether Mounjaro is clinically appropriate for your situation, our prescribers are available seven days a week. Speak to our prescribers through a free consultation and get a same-day clinical review.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.